Treating infants, children, teens, and young adults requires multiple medical and educational strategies. Appropriate therapy for a 6-year-old in first grade does not necessarily translate to success for 16-year-old in 10th grade. Indeed, each visit becomes an opportunity to try different techniques to establish both a rapport with the patient and... Read more
(Please note that this is a comprehensive blog - if you wish to see the conclusions and my recommendations only, feel free to skip to the end. Otherwise, it might be a good idea to read everything to understand recent developments.)
A recent publication in the journal Diabetologia suggested a possible link between the development of... Read more
Once again, at the suggestions of Allie Beatty and Ann Bartlett, I have checked out one of the newer technologies in early stages of development, Diabecell. According to LCT (living cell technologies) Diabecell is a "porcine (pig), insulin producing cell product for the treatment of type 1 diabetes mellitus. The islet cells are self-regulating and... Read more
David Mendosa recently posted a blog about "glycemic variability." Most people have come to expect that their diabetes control is primarily evaluated by the hb A1C level. Indeed, the hb A1c is correlated with a three-month estimated average glucose level, which is very helpful to know in terms of the effectiveness in medical (insulin or oral)... Read more
As a diabetologist at Children's National Medical Center, my job description goes beyond caring for patients, educating medical students/hospital residents, and participating in clinical research. Advocacy is also an essential component of my position. As I have emphasized in previous entries, the diabetes team helps to care and support our... Read more